Analysts polled by FactSet expected $1.58.
Net sales for the quarter ended April 25 were $8.93 billion, up from $8.59 billion a year earlier. Analysts surveyed by FactSet expected $8.81 billion.
For fiscal 2026, the company expects diluted non-GAAP EPS in the range of $5.50 to $5.60. Analysts polled by FactSet expect $5.82.
Medtronic said the dividend for fiscal Q1 increased to $0.71 per share from $0.70, payable on July 11 to shareholders of record at the close of business on June 27.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.